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Background: Non-specific electrocardiographic ST-T wave changes and voltage criteria for left ventricular hypertrophy
(LVH) have been associated with cardiovascular morbidity and mortality. The aim of the cohort study was to evaluate
the prognostic value of non-specific ST-T changes and LVH electrocardiographic criteria on cardiovascular events and
mortality in hypertensive patients.
Methods: A cohort study of 352 non-diabetic hypertensive patients, without associated cardiovascular disease,
randomly selected from 1,780 hypertensive patients attended in a primary care center. An electrocardiogram was
performed at the baseline visit (classified according to the Minnesota Code). Cardiovascular events and death
from any cause during the follow-up period were evaluated. A multivariate analysis adjusted for gender, age and
cardiovascular risk factors was performed.
Results: Data of 273 patients were analyzed: 58.2% women, age 44.1 (7.9) years, 27.8% smokers, blood pressure at
baseline 142.7 (15.3)/89.3 (9.6) mmHg. During the 197.5 (59.24) month follow-up, 62 patients (22.7%) had a
cardiovascular event. On multivariate analysis, age, systolic blood pressure, incidence of diabetes, smoking and
electrocardiographic LVH criteria (HR 2.66 [CI 95% 1.39 – 5.10]), were significantly associated with cardiovascular
events, but the presence of non-specific ST-T abnormalities (HR 0.97 [CI 95% 0.49 -1.90]) was not significantly
associated with cardiovascular morbidity and mortality.
Conclusions: Hypertensive patients with LVH electrocardiographic criteria have significantly higher cardiovascular
mortality and morbidity, but non-specific electrocardiographic ST-T changes are not associated with cardiovascular
morbidity and mortality.
Keywords: Electrocardiogram, Cardiovascular events, Hypertension, Left ventricular hypertrophy, Major and minor
electrocardiographic abnormalities, Repolarization electrocardiographic abnormalitiesBackground
The electrocardiogram (ECG) is a routine, accessible,
cost-effective and recommended diagnostic tool for the
initial evaluation and follow-up of hypertensive patients.
Despite its limitations, the utility of this exam cannot be
denied, both for the detection of left ventricular hyper-
trophy (LVH) and for cardiovascular risk stratification* Correspondence: 23561evb@comb.cat
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unless otherwise stated.and assessment of arrhythmias, blockages or coronary
artery disease [1].
Non-specific repolarization disorders represent the most
prevalent electrocardiographic abnormalities in hyperten-
sive patients [2] with an uncertain prognostic significance.
Many studies significantly associate non-specific ST-T
segment abnormalities with cardiovascular morbidity and
mortality, regardless of the populations or ethnic origin of
the patients [3-12]. In contrast, other studies found no sig-
nificant association during follow-up, at least in some sub-
groups of patients [13-15]. This prognostic variability isl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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larly regarding the follow-up time, the number of patients
included in each study, and the different inclusion criteria
used. Therefore, our study aims to provide information in
this regard from a cohort of hypertensive patients treated
within a primary care setting.
The goal of our study was to determine whether non-
specific baseline ST-T ECG abnormalities and LVH volt-
age criteria during follow-up were associated with a higher
incidence of cardiovascular events in hypertensive patients.
Methods
This is a prospective cohort study (MINACOR) that in-
cluded 352 hypertensive, non-diabetic patients with no
associated cardiovascular disease, registered and treated
at La Mina Primary Care Center, who were followed-up
from January 1992 to September 2011. La Mina Primary
Care Center is located in Sant Adrià de Besòs, municipal-
ity of Barcelona, and comprises 11 primary care offices. At
present, our primary care center provides medical services
to an urban catchment area of 11,373 adult patients, of
which 26.73% are hypertensive (according the our elec-
tronic medical records data base).
The design, structure and ethical points of the study
were approved by the Ethics Commission of Teaching
Unit of Family and Community Medicine in Barcelona
in 1991. All patient information was treated confidentially
in accordance with applicable law in Catalonia, with
standards of good clinical practice and in compliance
with the Helsinki Declaration. Informed consent was
obtained from patients and it was a compulsory inclu-
sion criteria.
The MINACOR cohort was started in 1992 with a base-
line visit. Over time, this cohort of patients has provided
information on the incidence of electrocardiographic ab-
normalities in hypertensive patients and on predictor
variables of electrocardiographic changes in the first few
years of follow-up [16-19].
Patient selection was made by systematic random sam-
pling over a total of 1,780 hypertensive patients <55 years,
registered and attended at the center in 1992. The criteria
for hypertension that were in place at that time were used:
mean blood pressure of three measurements at three
different visits ≥140/90 mmHg.
Patients with diabetes mellitus, or a prior diagnosis of
coronary artery disease, heart failure, valvular disease, or
atrial fibrillation were excluded [17].
Included patients had and ECG at the baseline visit that
was interpreted and classified according to the Minnesota
Code [20]. The design was previously published [19].
The baseline visit included the collection of demographic
data, office blood pressure values (average of two seated
readings using a calibrated mercury sphygmomanometer,
at a one minute interval from each other, and a special cufffor obese patients, when necessary), obesity (defined by a
body mass index ≥ 30 kg/m2), hypercholesterolemia (total
cholesterol >250 mg/dl or LDL cholesterol >155 mg/dl,
or HDL cholesterol <40 mg/dl in men or <48 mg/dl in
women, or the use of lipid-lowering medications [21],
diagnosis of active smoking (defined as a daily consump-
tion of any type of tobacco), heavy alcohol consumption
(>40 g/day for women and >80 g/day for men), presence
of electrocardiographic abnormalities and antihyperten-
sive drug treatment.
All ECGs were read only by two trained professionals
from the center (EV and MF). When there was disagree-
ment between the two readers regarding the interpret-
ation of the ECG, a third reading was done jointly with
the aim of reaching a final interpretation of the ECG.
The Cornell index (for men: RaVL + SV3 > 2.8 mV; for
women: RaVL + SV3 >2.0 mV) and the Sokolow-Lyon
index (SV1 + RV5 or V6> 3.5 mV) were evaluated as
electrocardiographic LVH criteria.
The incidence of diabetes mellitus (defined as 2 or more
basal glycemia ≥ 126 mg/dl) [22], the incidence of cardio-
vascular disease [cerebrovascular disease (stroke or transi-
ent ischemic attack); dementia from all causes; coronary
heart disease (myocardial infarction, stable angina or myo-
cardial revascularizations); heart failure; chronic kidney
disease (defined by the estimated glomerular filtration rate
according to the Cockroft-Gault formula normalized per
1.73 m2 <60 ml/min) [23] or peripheral arterial disease
(intermittent claudication, ankle brachial index< 0.9 or
carotid stenosis)], according to the patient’s clinical records
throughout the follow-up period, were assessed during the
entire course of the follow-up period.
The primary endpoint was a composite of fatal or non-
fatal cardiovascular events. In addition, death from any
cause during the follow-up period was also recorded. The
detection of cardiovascular events was conducted using
three methods: (1) review of the shared electronic medical
record for use in the primary care system of the Catalan
Institute of Health (ECAP), which includes 5.8 million
people attended in Catalonia; (2) a review of the medical
records in a paper format used at our center (records
between 1984 and 2005); and, (3) the mortality registry
of our center (updated monthly since 1986). When, des-
pite these three ways, the information could not be com-
pleted, each patient’s GP was asked directly at the actual
center (most GPs have been seeing patients continuously
at the center well before 1992 and the migration pattern
of the population attended is small). The doctors of those
patients whom we had been unable to reach contacted
their families to obtain the information.
Electrocardiographic abnormalities were divided into major
and minor abnormalities according to the Minnesota
Code (MC). Criteria for major ST-T abnormalities were:
MC 4–1, 5–1, and 5–2. Criteria for minor ST-T changes
Table 1 Baseline sociodemographic and clinical
characteristics of the total sample (n=273)
Women [n (%)] 160 (58.2)
Age [mean (SD)] (years) 44.1 (7.9)
Smoking [n (%)] 76 (27.8)
Heavy alcohol consumption [n (%)] 39 (14.3)
Blood pressure [mean (SD)] (mmHg)
Systolic 142.7 (15.3)
Diastolic 89.3 (9.6)
Obesity [n (%)] (BMI ≥ 30 kg/m2) 168 (61.5)
Dyslipidemia [n (%)] 127 (46.5)
Patients with antihypertensive treatment [n (%)] 173 (63.3)
Diuretics 80 (29.1)
Beta blockers 54 (19.6)
Angiotensin-converting-enzyme inhibitors 54 (19.6)
Calcium channel antagonists 46 (16.7)
Baseline electrocardiographic ST-T changes and left ventricular
hypertrophy* [n (%)]:
Major ST (MC 9–2; 4–1; 4–2) 15 (5.5)
Inverse Major T wave (MC 5–1; 5–2) 6 (2.2)
Inverse Minor T wave (MC 5–3) 16 (5.9)
Minor ST (MC 4–3) 5 (1.8)
Left ventricular hypertrophy (Cornell criteria) 24 (8.7)
SD: standard deviation; BMI: body mass index; A-V: atrioventricular; MC:
Minessota code.
*A total of 52 patients had 66 basal electrocardiographic abnormalities.
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ST-T abnormalities were considered and analyzed as hav-
ing major ST-T changes.Statistical analysis
Incidence rates per 1000 patients/year were calculated
for both cardiovascular morbidity and mortality (having
suffered a cardiovascular event or death from cardiovas-
cular causes) and for each cardiovascular event and mor-
tality from cardiovascular causes.Table 2 All cardiovascular events during follow-up (n=62 pati
N
Coronary heart disease 21(5†)
Peripheral artery disease 14
Chronic kidney disease 18 (2†)
Cerebrovascular disease 9 (3†)
Dementia 6
Heart failure 6
Other (not included in the primary endpoint)^ 8
*47 patients had one cardiovascular event, 10 patients had 2 cardiovascular events
considered for the analysis.
†Number of deceased patients; ^ Atrial fibrillation (6 patients), Mobitz Type II A-V bThe 95% confidence intervals were calculated assuming
a Poisson distribution.
Survival curves were calculated using the Kaplan-Meier
method for cardiovascular morbidity and mortality separ-
ately for those who had or did not have any non-specific
ST-T abnormalities, major ST-T abnormalities, minor
ST- T and LVH according to electrocardiographic criteria.
The comparisons between survival curves, according to inde-
pendent variables, were calculated using the Log-Rank test.
Cox proportional hazards models were estimated to as-
sess the relationship between variables and the occurrence
of events (cardiovascular morbidity and mortality) ad-
justed for the follow-up time. Marginally significant
variables, those considered clinically relevant, and all
major interactions were included in the univariate analysis
(p <0.10). The hazard ratio (HR) estimation and its
95% confidence interval are provided for each of the
final models.
A combined variable was defined as the primary endpoint
of the study: time free of cardiovascular disease or death
from a cardiovascular origin (cardiovascular morbidity and
mortality).
Results
A total of 352 patients were initially included, of which
77 were lost to follow-up. Two other patients were
withdrawn from the study because they had an illegible
ECG at baseline. Finally, 273 hypertensive patients were
assessed. The majority of them were women (58.2%) with
a mean age of 44.1 (7.9) years. From the total number
of patients, nearly one third were smokers. At the base-
line visit, the mean values of systolic and diastolic blood
pressure were 142.7 (15.3) mmHg and 89.3 (9.6) mmHg,
respectively. A total of 173 patients were under antihyper-
tensive treatment (121 patients with one drug, 43 with
two drugs and 9 with three drugs), and 19 (7%) patients
had subclinical organ damage at the baseline visit, accord-
ing to medical records. Nevertheless the prevalence of
LVH was 8.7% (Cornell criteria). No patient met Sokolow-
Lyon criteria.ents; 82 events*)
% Incidence rate per 1000 patients/year [95% CI]
7.7 4.84 [3 – 7.4]
5.1 3.23 [1.8 – 5.4]
6.6 4.15 [2.5 – 6.6]
3.3 2.07 [0.9 – 3.9]
2.2 1.38 [0.5 – 3.01]
2.2 1.38 [0.5 – 3.01]
2.9 1.84 [0.8 – 3.6]
and 5 patients had 3 cardiovascular events. Only first cardiovascular event was
lock (1 patient), subclavian artery stenosis (1 patient); CI: confidence interval.
Figure 1 Time to First Cardiovascular Event Kaplan-Meier Estimates (p=0.385).
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electrocardiographic abnormality or Cornell criteria: 17
patients had isolated LVH criteria, 28 patients had an
isolated ST-T change (16 patients with major abnormal-
ities and 12 patients with minor abnormalities), and 7
patients had both LVH and ST-T abnormalities (3 patients
with major abnormalities and 4 patients with minor
abnormalities) (Table 1).There were no statistically
significant differences between patients with and with-
out electrocardiographic abnormalities, except for sys-
tolic blood pressure which was higher in subjects withFigure 2 Time to First Cardiovascular Event Kaplan-Meier Estimates (pelectrocardiographic abnormalities [147 (15.8) mmHg
vs. 141 (15.0) mmHg, p=0.03].
The mean follow of the sample was 197.5 months (59.24).
The median follow-up among men was 205.7 months (95%
CI 195.6 to 215.8) and 210.9 months among women (95%
CI 203.5 to 218.4).
A total of 84 patients (30.5%) had incident diabetes
mellitus during the follow-up time.
Of the 273 patients, 62 patients had 82 cardiovascular
events during follow-up: 47 patients had one single car-
diovascular event, 10 patients had two and 5 patients=0.003) Months.
Table 3 Risk for cardiovascular outcomes or cardiovascular mortality
HR [95% CI] adjusted for gender, age, SBP,
DM2 incidence, LVH and smoking
P-value Crude HR [95% CI] P- value
LVH, Cornell criteria 2.66 [1.39 – 5.10] 0.003 2.47 [1.39 – 4.60] 0.005
Gender (Male) 0.58 [0.24 – 1.40] 0.223 1.18 [0.73 – 1.90] 0.491
Age 1.07 [1.03 – 1.12] 0.002 1.07 [1.02 – 1.11] 0.003
SBP 1.01 [0.99 – 1.03] 0.108 1.02 [1.00 – 1.03] 0.022
DM incidence 1.63 [0.99 – 2.68] 0.055 2.08 [1.30 - 3.30] 0.003
Smoking 0.68 [0.16 – 2.88] 0.603 1.71 [1.05 - 2.80] 0.033
Male * Smoking 6.17 [1.11 – 34.24] 0.038 2.00 [1.21 - 3.31] 0.007
Hazard ratios were estimated by using proportional hazards (Cox) regression modeling with LVH.
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follow-up period, 36 patients died (13.1%), 10 from car-
diovascular causes (three patients died from cerebrovascu-
lar disease, three patients died from sudden cardiac death,
two patients died from acute myocardial infarction and
two patients died from chronic kidney disease).
With regard to the presence or absence of major or
minor abnormalities as per the findings from the base-
line ECG, there was no statistically significant difference
in cardiovascular event-free survival [209.4 (8.0) vs 208.7
(3.3) months, p = 0.385 respectively)]. Isolated major or
isolated minor ST-T changes didn’t predict cardiovascular
events (the combined morbidity and mortality endpoint).
However, a statistically significant difference was seen in
event-free survival when patients with baseline electrocar-
diographic LVH criteria were compared to the rest of
patients [186.1 (12.6) vs 211.0 (3.1) months, p = 0.003,
respectively)] (Figure 1 and Figure 2).
Table 3 and Table 4 describes the variables associated
with the incidence of cardiovascular events during the
follow-up time. LVH was the only electrocardiographic
abnormality that was significantly associated with cardio-
vascular endpoint (morbidity and mortality).
A separate subanalysis of cardiovascular morbidity and
mortality was also performed. The hazard ratio (HR) for
cardiovascular morbidity in patients with baseline LVH
was 3.11 [CI 95% 1.61 – 6.01], p<0.001, and in patients
with non-specific ST-T abnormalities was 0.88 [CI 95%Table 4 Risk for cardiovascular outcomes or cardiovascular m
HR [95% CI] adjusted for gender, ag
major or minor ECG abnormalities a
Major or minor ECG abnormalities 0.97 [0.49 -1.90]
Gender (Male) 1.08 [0.59 - 1.96]
Age 1.07 [1.03 - 1.12]
SBP 1.01 [1.00 - 1.03]
DM incidence 1.97 [1.21 - 3.20]
Smoking 1.98 [1.06 - 3.70]
LVH, Left Ventricular Hypertrophy; HR: Hazard Ratio; SBP, Systolic Blood Pressure; DM
Hazard ratios were estimated using proportional hazards (Cox) regression modeling0.41 – 1.87], p=0.745, adjusting for age, sex, blood pres-
sure, smoking and diabetes. When only cardiovascular
mortality (n=10) was analyzed, LVH and the combined
non-specific ST-T changes lost their predictive value.
Nevertheless isolated major ST-T changes predicted car-
diovascular mortality: HR 5.06 [CI 95% 1.20 – 21.36],
p=0.027, adjusting for age, sex, smoking and heavy alco-
hol consumption.
Discussion
Unlike other studies, our study does not demonstrate that
non-specific abnormalities of the terminal segment of the
electrocardiogram are associated with cardiovascular
morbidity and mortality over a mean follow-up period
of more than 16 years of a cohort of hypertensive pa-
tients. In contrast, statistically significant associations were
indeed found with other previously known and assessed
cardiovascular risk factors such as age, smoking (especially
in males), the incidence of diabetes mellitus, systolic blood
pressure and electrocardiographic LVH voltage criteria.
These associations between classic risk factors and cardio-
vascular events are consistent with previous evidence.
In a way, these associations confirm that patient follow-up
quality and data collection is adequate. Hence, it indirectly
reinforces the main finding yielded by our study, which is
the lack of association between global major and minor
ST-T segment changes and cardiovascular events in hyper-
tensive patients. As discussed in the introduction section,ortality
e, SBP, DM2 incidence,
nd smoking
P-value Crude HR [95% CI] P-value
0.923 1.33 [0.69 - 2.54] 0.387
0.804 1.18 [0.73 - 1.90] 0.491
0.002 1.07 [1.02 - 1.11] 0.003
0.053 1.02 [1.00 - 1.03] 0.022
0.006 2.08 [1.30 - 3.30] 0.003
0.032 1.71 [1.05 - 2.80] 0.033
: Type 2 Diabetis; CI, confidence interval.
with major or minor electrocardiographic (ECG) abnormalities.
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the study by De Bacquer et al. [13] only certain non-
specific changes of the terminal segment were associated
with cardiovascular morbimortality, such as major abnor-
malities of the ST-T segment and, in contrast, this associ-
ation did not occur with minor changes of the ST-T
segment. In our study, when a separate mortality and
morbidity sub analysis was performed, we also found a
significant association between isolated major ST-T
changes and cardiovascular mortality. Nevertheless the
low number of cardiovascular deaths (n=10) does not
allow to reach a definitive conclusion.
In other studies, such as the one by Liao et al. [14], there
was only statistical significance for men -with increased
cardiovascular risk- but not for women. It is possible that
we may not have found any prognostic value of non-
specific changes of the terminal segment due to the low
baseline cardiovascular risk of the cohort. Although more
than half of the sample consisted of obese and dyslipemic
patients, in fact, these patients were hypertensive relatively
young, with a mean age of 44 years, with only 7% of
asymptomatic organ damage and without diabetes. There-
fore, at the end of follow-up, most patients were about 60
years old. We do not know whether a longer follow-up, or
older patients, would have been useful to demonstrate the
global predictive value of non-specific abnormalities of
ST-T segment. Instead, we found association between
cardiovascular events and LVH, which is significant
after 8 years of follow-up. Probably, ECG-detected LVH,
poses a situation of increased cardiovascular risk than
non-specific changes in the ST-T segment, although the
later represent the most prevalent electrocardiographic
abnormality shown in ECGs of hypertensive patients.
Some years back, in that same cohort, it was demonstrated
that the incidence of major or minor non-specific changes
were associated to a worse control of blood pressure [17].
In fact, we found that patients with baseline electrocar-
diographic abnormalities had significantly higher systolic
blood pressure than patients with a normal electrocardio-
gram. Therefore, non-specific ST-T changes could be early
indicators of a poor management of blood pressure and,
in the long term, could predict subclinical organ damage
such as LVH itself. In any case, the design of our study
cannot prove it and this approach is just a mere hypoth-
esis that should be confirmed in other studies.
One of the limitations encountered is the lack of repro-
ducibility of ST-T segment changes on successive ECG,
and what the variability attributable to the observer is, es-
pecially in the case of minor abnormalities. We know that
in terms of routine clinical practice, the reproducibility of
Sokolow and Cornell electrocardiographic voltage criteria
is moderate [24], but the major and minor criteria of the
ST-T segment still pose reproducibility problems. In our
experience, when two ECG are conducted on the samepatient, in the best case scenario, the kappa index between
both ECGs in relation to major and minor abnormalities
is only 0.65 [95% CI 0:26 to 1:04] and 0.57 [95% CI,
0.40-0.74], respectively [25]. Our results are based solely
on the performance of one single ECG. In addition, the
low number of ST-T non-specific electrocardiographic
abnormalities could be another limitation of our study.
On the other hand, the high rate of follow-up losses −77
patients (26%)- may have affected the results by adding a
selection bias. This is another potential study limitation.
Moreover, we have no information about changes in an-
tihypertensive drug treatment during the follow-up time.
Despite these limitations, the classical cardiovascular risk
factors and LVH voltage criteria maintain their prognostic
value.
Conclusions
We conclude that LVH electrocardiographic changes seen
on the ECG are significantly associated with cardiovas-
cular morbidity and mortality. However, globally non-
specific repolarization disorders have no prognostic value
in our cohort of hypertensive patients.
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